Package 61958-2301-1

Brand: vemlidy

Generic: tenofovir alafenamide
NDC Package

Package Facts

Identity

Package NDC 61958-2301-1
Digits Only 6195823011
Product NDC 61958-2301
Product ID 61958-2301_175f5d1a-aae9-43d5-b004-65eefec167d4
Description

30 TABLET in 1 BOTTLE, PLASTIC (61958-2301-1)

Marketing

Marketing Status
Marketed Since 2016-11-10
Brand vemlidy
Generic tenofovir alafenamide
Sample Package No

Linked Drug Pages (1)

VEMLIDY ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "175f5d1a-aae9-43d5-b004-65eefec167d4", "openfda": {"unii": ["FWF6Q91TZO"], "rxcui": ["1858261", "1858267"], "spl_set_id": ["72e6b33c-0351-4070-9172-eeaa186c01d2"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2301-1)", "package_ndc": "61958-2301-1", "marketing_start_date": "20161110"}], "brand_name": "VEMLIDY", "product_id": "61958-2301_175f5d1a-aae9-43d5-b004-65eefec167d4", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "61958-2301", "generic_name": "tenofovir alafenamide", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VEMLIDY", "active_ingredients": [{"name": "TENOFOVIR ALAFENAMIDE FUMARATE", "strength": "25 mg/1"}], "application_number": "NDA208464", "marketing_category": "NDA", "marketing_start_date": "20161110", "listing_expiration_date": "20261231"}